Celyntra Therapeutics SA
12.7 FTECelyntra Therapeutics reported total assets of €8.20m at the end of the 2025 financial year (annual accounts filed with the NBB on 10 Jun 2026), with 12.7 full-time equivalents.
By total assets for 2025, Celyntra Therapeutics ranks among the 200 largest of the 968 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Celyntra Therapeutics shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +7709 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Celyntra Therapeutics's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Jun 2026
- Year ended 31 Dec 2024filed on 16 Oct 2025
- Year ended 31 Dec 2023filed on 24 Jul 2024
- Year ended 31 Dec 2022filed on 30 Jun 2023
- Year ended 31 Dec 2021filed on 23 Sep 2022
Celyntra Therapeutics's financial analysis
- Solvency-117.1%sector median: 44.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Celyntra Therapeutics
Celyntra Therapeutics's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0737.829.015
- VAT number
- BE0737829015
- Peppol
- Registered · 0208:0737829015 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 19 Nov 2019
- Registered office
- 1435 Mont-Saint-Guibert
- Size
- Small · 12.7 FTE
- Latest accounts
- 2025 · filed on 10 Jun 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Celyntra Therapeutics (SA) has been based in Mont-Saint-Guibert since 2019, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of €3.07m and equity of −€9.60m; its revenue is not published. With 12.7 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at -117.1%, below the median of its sector (44.7%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Celyntra Therapeutics
Companies in the same business, of comparable size and area, outside its group.
- Arkopharma Belux Wholesale of pharmaceutical and medical goods Wavre · balance sheet €5.33m
- Depharm Wholesale of pharmaceutical and medical goods Wavre · balance sheet €26.8m
- Bausch & Lomb Pharma Wholesale of pharmaceutical and medical goods Wavre · balance sheet €9.17m
- UPSA Belgium Wholesale of pharmaceutical and medical goods Etterbeek · balance sheet €104.2m
- Etablissements Henri Nootens Wholesale of pharmaceutical and medical goods Schaerbeek · balance sheet €5.13m
- Almirall Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €7.75m
- BIOCODEX Benelux Wholesale of pharmaceutical and medical goods Forest · balance sheet €8.15m
- Zambon Wholesale of pharmaceutical and medical goods Jette · balance sheet €7.67m
Frequently asked questions about Celyntra Therapeutics
What is the revenue of Celyntra Therapeutics?
Celyntra Therapeutics files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Celyntra Therapeutics?
In Belgium, the VAT number is the company number prefixed with BE: BE0737829015 for Celyntra Therapeutics, if the company is VAT-registered. Its company number (CBE) is 0737.829.015.
Where is the registered office of Celyntra Therapeutics?
According to the CBE register, the registered office of Celyntra Therapeutics is in 1435 Mont-Saint-Guibert.
What is the equity of Celyntra Therapeutics?
At the close of the 2025 financial year, the equity of Celyntra Therapeutics amounts to -9,597,948 €, a solvency of -117.1% of total assets.
How many people work at Celyntra Therapeutics?
12.7 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Celyntra Therapeutics?
The register lists 1 active mandates at Celyntra Therapeutics. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Celyntra Therapeutics within its sector?
By total assets for 2025, Celyntra Therapeutics ranks among the 200 largest of the 968 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year.
The full file of Celyntra Therapeutics
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →